{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:20:17Z","timestamp":1794651617879,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5729,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1111\/j.1538-7836.2007.02424.x","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T11:29:21Z","timestamp":1175513361000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders"],"prefix":"10.1016","volume":"5","author":[{"given":"V.","family":"DE STEFANO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"FIORINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"ROSSI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"ZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"FARINA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"CHIUSOLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"SICA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"LEONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20\u2003years","volume":"123","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0020","first-page":"215","article-title":"Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation","volume":"89","author":"Barbui","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/BF01725198","article-title":"Budd\u2013Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases","volume":"67","author":"Anger","year":"1989","journal-title":"Klin Wochenschr"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s002770050555","article-title":"Thrombosis\u2010free survival and life expectancy in 187 consecutive patients with essential thrombocythemia","volume":"78","author":"Bazzan","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-996117","article-title":"Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd\u2013Chiari syndrome or portal vein thrombosis","volume":"23","author":"De Stefano","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0045","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd\u2013Chiari syndrome and portal vein thrombosis: results of a case\u2013control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0050","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","article-title":"Extrahepatic portal vein thrombosis: aetiology and determinants of survival","volume":"49","author":"Janssen","year":"2001","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction","volume":"41","author":"Primignani","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","article-title":"Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis","volume":"129","author":"Chait","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-2006-939432","article-title":"Budd\u2013Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management","volume":"32","author":"Bri\u00e8re","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMra042354","article-title":"Thrombosis of the cerebral veins and sinuses","volume":"352","author":"Stam","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd\u2013Chiari syndrome","volume":"103","author":"Valla","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0080","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","article-title":"Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders","volume":"94","author":"Valla","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0085","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0090","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0100","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain\u2010of\u2010function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0110","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0115","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2005.05764.x","article-title":"JAK2 mutation in essential thrombocythaemia: clinical associations and long\u2010term prognostic relevance","volume":"131","author":"Wolanskyj","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0125","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.leu.2403902","article-title":"Clinical implications of the JAK2 V617F mutation in essential thrombocythemia","volume":"19","author":"Antonioli","year":"2005","journal-title":"Leukemia"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.21645","article-title":"The clinical phenotype of wild\u2010type, heterozygous, and homozygous JAK2V617F in polycythemia vera","volume":"106","author":"Tefferi","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2141.2005.05858.x","article-title":"The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia","volume":"132","author":"Cheung","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0145","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2005-04-1515","article-title":"The Jak2V617F mutation, PRV\u20101 overexpression, and EEC formation define a similar cohort of MPD patients","volume":"106","author":"Goerttler","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2V617F: prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0155","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0160","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","article-title":"Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd\u2013Chiari syndrome","volume":"130","author":"Patel","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0165","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","article-title":"Role of the JAK2V617F mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis","volume":"44","author":"Primignani","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2007.02424.x_bb0175","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation.V2000.1.51.51","article-title":"A polycythemia vera update: diagnosis, pathobiology, and treatment","author":"Pearson","year":"2000","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0185","first-page":"1095","article-title":"Screening for inherited thrombophilia: indications and therapeutic implications","volume":"87","author":"De Stefano","year":"2002","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2141.1999.01613.x","article-title":"Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease","volume":"106","author":"De Stefano","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0195","first-page":"2139","article-title":"Polycythemia vera","volume":"69","author":"Stuart","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0002-9343(96)00351-8","article-title":"Inapparent polycythemia vera: an unrecognized diagnosis","volume":"102","author":"Lamy","year":"1997","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0205","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2003-02-0443","article-title":"Hyperhomocysteinemia in cerebral vein thrombosis","volume":"102","author":"Martinelli","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0210","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano\u2010Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2007.02424.x_bb0215","first-page":"705","article-title":"Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative disease","volume":"18","author":"Lang","year":"1982","journal-title":"Isr J Med Sci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02424.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622101789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622101789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02424.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:42:32Z","timestamp":1761532952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622101789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1538783622101789"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02424.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02424.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}